Anavex Life Sciences Corp.'s stock rises 50% as EMA reviews Alzheimer's drug blarcamesine. Click for my updated look at AVXL stock and why I have upgraded it.

Alzheimer's disease, a type of dementia that profoundly alters a person’s memory and cognitive function, affects an estimated ...

Progressive and incurable, Alzheimer’s disease affects an estimated 6.7 million U.S. adults at least 65 years old, according ...

Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s,” Charles Piller looks how the amyloid hypothesis took over ...

There exists no ‘amyloid cabal’” in Alzheimer’s research, neurologist Dennis Selkoe writes in response to Charles Piller’s ...

New drugs for early Alzheimer’s disease may allow people to live without help for up to 39 additional months, a new study ...

1️⃣ Drowning in debt: Americans are finding it harder to pay off their debt — specifically for auto loans and credit cards.

Your brain’s natural rinse cycle flows while you sleep. A new study suggests certain medications interfere with that ...

Caring for Our Own seminar included panels on Alzheimer's and other forms of dementia, as well as tips on preparing for ...

In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from clinical trials showing that both drugs slowed the progression of the disease.

US researchers behind the new analysis said they hoped the findings would help patients weigh up the potential benefits of ...